Abstract:
A method and apparatus for analyzing genetic information of abnormal tissue, the method and apparatus involving obtaining a first set of sequence data that includes one or more pieces of sequence data that are aligned in one or more single nucleotide polymorphism (SNP) sites from genetic samples of abnormal tissue; obtaining a second set of sequence data that includes one or more pieces of sequence data that are aligned in one or more SNP sites from genetic samples of normal tissue; analyzing, by a processing unit, a distribution of alleles in corresponding portions of the first set of sequence data and the second set of sequence data; and determining a contamination rate of a sample of a tissue by using a result of the analyzing.
Abstract:
A method and apparatus for analyzing personalized multi-omics data are disclosed. The method includes acquiring a plurality of biological data groups from an individual's gene sample, estimating indices indicating a degree of genetic abnormalities for the biological data groups, and generating a combined index by merging the estimated indices.
Abstract:
Biomarkers for screening drugs reducing side effects of anti-c-Met antibodies and a method of screening using the biomarkers, and more particularly, biomarkers commonly enhancing or reducing gene expression and a method of screening anti-c-Met antibodies having reduced side effects using the biomarkers or a method of screening drugs that reduce side effects of anti-c-Met antibodies.
Abstract:
A method and apparatus for analyzing information about a gene network in which genes included in a genome of an individual are classified into a plurality of subgroups based on functional correlations between the genes is acquired, and subgroups corresponding to an action of at least one drug to be used are visualized.